Source: International Congress 2019 – Damage and remodelling in pulmonary fibrosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Boutanquoi (Dijon, France), G. Beltramo (Dijon, France), L. Dondaine (Dijon, France), P. Bellaye (Dijon, France), O. Burgy (Aurora, United States of America), B. Crestani (Paris, France), C. Garrido (Dijon, France), F. Goirand (Dijon, France), P. Bonniaud (Dijon, France). LSC - 2019 - TRIM33 regulates TGF-ß1 secretion and Epithelial-Mesenchymal Transition in pulmonary fibrosis. 2110

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Calpain regulates epithelial-mesenchymal transition and its correlation with Akt signaling in pulmonary fibrosis. Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias Year: 2018 MiR-31 regulates IRF-1 function in cystic fibrosis epithelial cells Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine Year: 2014 Identification of novel proteins involved in beta-catenin dependent alveolar epithelial trans-differentiation Source: International Congress 2014 – New and old players in fibrotic lung disease Year: 2014 KCa3.1 mediates alphaSMA expression in human lung myofibroblast via the Smad2/3 and TGFbeta1 signalling pathway Source: International Congress 2014 – Cell biology 2014 Year: 2014 Late Breaking Abstract - Caveolin-1 derived peptide LTI-03 promotes epithelial cell survival and attenuates pulmonary fibrosis Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia Year: 2019 LSC - 2020 - GCN2 signalling is dysregulated in pulmonary fibrosis Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Defective A20 signalling in CF: Anti-inflammatory action of gibberellins Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science Year: 2013 Involvement of JNK in TNFα driven remodelling Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 Toll like receptor 4 activation upregulates miR-181b attenuating pulmonary fibrosis via targeting TGFBR1 Source: International Congress 2015 – Latest news on miRNAs in pulmonary research Year: 2015 Late Breaking Abstract - Loss of PTEN induces alveolar epithelial cell senescence resulting in lung fibrosis via activated NF-?B Source: International Congress 2018 – ILDs: From bench to bedside Year: 2018 LSC - 2019 - Development of pulmonary fibrosis in conditional Nedd4-2 deficient mice Source: International Congress 2019 – Damage and remodelling in pulmonary fibrosis Year: 2019 Epidermal growth factor receptor (EGFR) activation is required for TGFbeta1-induced epithelial-mesenchymal transition (EMT) in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013 Metformin inhibits TGF-b-induced myofibroblast differentiation through AMPK activation Source: International Congress 2014 – Cell biology 2014 Year: 2014 Decreased PTEN amplifies PI3K signaling and enhances pro-inflammatory cytokine release in COPD Source: International Congress 2016 – Studies in airway cell biology Year: 2016 Accelerating lung epithelial cell senescence in reduced CARM1 mice enhances elastase-induced emphysema Source: International Congress 2014 – Mechanisms of COPD: proteases and a whole lot more Year: 2014 Up-regulation of EGFR gene family in COPD patients: Correlation with airway obstruction Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 Altered protein homeostasis in pulmonary fibrosis indicates a role for proteasomal activator 200 Source: International Congress 2014 – New and old players in fibrotic lung disease Year: 2014 Regulation of interleukin-8 by miR-17 during chronic inflammation in cystic fibrosis Source: International Congress 2015 – The multiple faces of host defense Year: 2015 SRC family kinase inhibition reduces NOX4 expression in bronchial epithelial cells from Idiopathic Pulmonary Fibrosis patients Source: International Congress 2019 – Damage and remodelling in pulmonary fibrosis Year: 2019